StreetAlpha
Pelthos Therapeutics Inc. · SEC Form 4

PTHS Insider Trading

From SEC Form 414 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Pelthos Therapeutics Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $1000K bought and $486K sold.

← PTHS stock page

Insiders are net buyers
Bought, 12 months$1000K1 buys · 1 insiders
Sold, 12 months$486K13 sales · 5 insiders
Net+$514Kbought minus sold
Planned sales34%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMar2026-04: sold $57KApr2026-05: sold $40KMay2026-06: bought $1000K2026-06: sold $8KJun2026-07: sold $56KJulAugSep2026-10: sold $45KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when PTHS insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an PTHS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every PTHS insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 2, 2026Matthew PaulsDirectorSale plan786$21.00$17K13,578Oct 6Form 4
Oct 2, 2026Ezra M FriedbergDirectorSale plan558$20.72$12K80,484Oct 6Form 4
Oct 2, 2026Peter GreenleafDirectorSale plan797$21.17$17K23,087Oct 6Form 4
Jul 2, 2026Peter GreenleafDirectorSale plan797$26.13$21K23,884Jul 7Form 4
Jul 2, 2026Matthew PaulsDirectorSale plan786$26.16$21K14,364Jul 7Form 4
Jul 2, 2026Ezra M FriedbergDirectorSale plan558$26.09$15K81,042Jul 7Form 4
Jun 15, 2026Ezra M FriedbergDirectorSale plan283$27.29$8K81,600Jun 17Form 4
Jun 11, 2026Todd C DavisDirectorBuy35,948$27.82$1000K75,834Jun 15Form 4
May 22, 2026Knuettel Francis IICFO, Treas & SectySale1,500$26.84$40K11,316May 26Form 4
Apr 2, 2026Peter GreenleafDirectorSale plan797$20.92$17K24,681Apr 6Form 4
Apr 2, 2026Matthew PaulsDirectorSale plan786$20.92$16K15,150Apr 6Form 4
Apr 2, 2026Ezra M FriedbergDirectorSale plan558$20.92$12K82,027Apr 6Form 4
Apr 2, 2026Richard MalamutDirectorSale plan590$20.92$12K27,422Apr 6Form 4
Nov 25, 2025Ezra M FriedbergDirectorSale10,000$28.03$280K30,000Nov 26Form 4

PTHS insider trading FAQ

Are PTHS insiders buying or selling?

Insiders are net buyers over the last 12 months. 1 insiders bought $1000K of PTHS on the open market in 1 trades, and 5 sold $486K in 13 trades, 34% of that under pre-arranged trading plans.

When did an PTHS insider last buy shares?

Todd C Davis (Director) bought 35,948 shares for $1000K on Jun 11, 2026, reported on Jun 15, 2026.

When did an PTHS insider last sell shares?

Matthew Pauls (Director) sold 786 shares for $17K on Oct 2, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice